https://www.selleckchem.com/pr....oducts/pterostilbene
14-0.49; P 0.0001). Patients with severe PCM had a higher NLR that was greater than the median (≥4.11). The NLR biomarker complements the criteria for PCM severity. Applying the low-cost NLR test can greatly increase the diagnostic sensitivity when screening patients for PCM and contribute to better control of the disease, management of complications, and therapeutic strategies. The NLR biomarker complements the criteria for PCM severity. Applying the low-cost NLR test can greatly increase the diagnostic sensitivity when scre
Like
Comment
Share
